Results 31 to 40 of about 216,526 (119)

Safety and Efficacy of Antithrombotic Strategies in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Network Meta-analysis of Randomized Controlled Trials.

JAMA cardiology, 2019
Importance The antithrombotic treatment of patients with atrial fibrillation (AF) and coronary artery disease, in particular with acute coronary syndrome (ACS) and/or percutaneous coronary intervention (PCI), poses a significant treatment dilemma in ...
R. Lopes, H. Hong, R. Harskamp, Deepak L. Bhatt, R. Mehran, C. Cannon, C. Granger, F. Verheugt, Jianghao Li, J. T. ten Berg, N. Sarafoff, C. Gibson, J. Alexander   +12 more
semanticscholar   +1 more source

Management of Percutaneous Coronary Intervention Complications

Circulation. Cardiovascular Interventions, 2020
Complications of percutaneous coronary intervention (PCI) may have significant impact on patient survival and healthcare costs. PCI procedural complexity and patient risk are increasing, and operators must be prepared to recognize and treat complications,
Jacob A. Doll, Ravi S Hira, Kathleen E. Kearney, D. Kandzari, Robert F. Riley, S. Marso, J. Grantham, C. Thompson, J. McCabe, D. Karmpaliotis, A. Kirtane, W. Lombardi   +11 more
semanticscholar   +1 more source

Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention

Circulation, 2019
Supplemental Digital Content is available in the text.
P. Urban, R. Mehran, R. Colleran, D. Angiolillo, R. Byrne, D. Capodanno, T. Cuisset, D. Cutlip, P. Eerdmans, J. Eikelboom, A. Farb, C. Gibson, J. Gregson, M. Haude, S. James, Hyo‐Soo Kim, Takeshi Kimura, A. Konishi, J. Laschinger, M. Leon, P. A. Magee, Yoshiaki Mitsutake, D. Mylotte, S. Pocock, M. Price, S. Rao, E. Spitzer, E. Spitzer, N. Stockbridge, M. Valgimigli, O. Varenne, Ute Windhoevel, R. Yeh, M. Krucoff, Mitchell W. Krucoff, M. Morice   +35 more
semanticscholar   +1 more source

Platelet Inhibition With Cangrelor and Crushed Ticagrelor in Patients With ST-Segment–Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: Results of the CANTIC Study

Circulation, 2019
Background: The platelet inhibitory effects induced by oral P2Y12 receptor antagonists are delayed in patients with ST-segment–elevation myocardial infarction undergoing primary percutaneous coronary intervention (P-PCI).
Francesco Franchi, F. Rollini, A. Rivas, Mustafa Wali, Maryuri Briceno, Malhar Agarwal, Zubair Shaikh, Ahmed Nawaz, Gabriel Silva, L. Been, Ramez Smairat, Marc Kaufman, Andres M Pineda, S. Suryadevara, D. Soffer, M. Zenni, T. Bass, D. Angiolillo   +17 more
semanticscholar   +1 more source

Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention.

Circulation, 2018
The optimal antithrombotic treatment regimen for patients with atrial fibrillation undergoing percutaneous coronary intervention with stent implantation represents a challenge in clinical practice. In 2016, an updated opinion of selected experts from the
D. Angiolillo, S. Goodman, Deepak L. Bhatt, J. Eikelboom, M. Price, D. Moliterno, C. Cannon, J. Tanguay, C. Granger, L. Mauri, D. Holmes, C. Gibson, D. Faxon   +12 more
semanticscholar   +1 more source

Fractional flow reserve-guided percutaneous coronary intervention vs. medical therapy for patients with stable coronary lesions: meta-analysis of individual patient data

European Heart Journal, 2018
Aims To assess the effect of fractional flow reserve (FFR)-guided percutaneous coronary intervention (PCI) with contemporary drug-eluting stents on the composite of cardiac death or myocardial infarction (MI) vs.
F. Zimmermann, E. Omerovic, S. Fournier, H. Kelbæk, N. Johnson, M. Rothenbühler, P. Xaplanteris, M. Abdel-Wahab, E. Barbato, D. Høfsten, P. Tonino, Bianca M. Boxma-de Klerk, W. Fearon, L. Køber, P. Smits, B. de Bruyne, N. Pijls, P. Jüni, T. Engstrøm   +18 more
semanticscholar   +1 more source

Effects of ischemic postconditioning on expressions of pentraxin-related protein 3 and neutrophil CD11b in the plasma of patients with acute myocardial infarction after percutaneous coronary intervention [PDF]

, 1969
Sheng-Hui Liu, Yu-E Huo, Xinwei Jia, Ya Li   +3 more
openalex   +1 more source

Contemporary Issues in Chronic Total Occlusion Percutaneous Coronary Intervention.

JACC: Cardiovascular Interventions, 2022
L. Azzalini, D. Karmpaliotis, Ricardo Santiago, K. Mashayekhi, C. Di Mario, S. Rinfret, W. Nicholson, M. Carlino, M. Yamane, E. Tsuchikane, E. Brilakis   +10 more
semanticscholar   +1 more source

Administration of Abciximab During Percutaneous Coronary Intervention Reduces Both Ex Vivo Platelet Thrombus Formation and Fibrin Deposition [PDF]

, 1998
George Dangas, Juan J. Badimón, Barry S. Coller, John T. Fallon, Sanjeev Sharma, Richard M. Hayes, Perwaiz Meraj, John A. Ambrose, Jonathan D. Marmur   +8 more
openalex   +1 more source

Coronary artery bypass grafting (CABG) vs. percutaneous coronary intervention (PCI) in the treatment of multivessel coronary disease: quo vadis? -a review of the evidences on coronary artery disease.

Annals of Cardiothoracic Surgery, 2018
The optimal treatment of ischemic coronary artery disease (CAD) is still controversial. A number of randomized controlled trials (RCT) and several meta-analyses have been performed and are inspiring the current guidelines.
C. Spadaccio, U. Benedetto
semanticscholar   +1 more source